Showing results (111-120 of 15,737) with videos related to

Sort By:
Pageof 1,574
The Journal of Antimicrobial Chemotherapy|May 11, 2002
Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniaeGeorge G Zhanel, Danielle Roberts, Andrew Waltky, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2002
In vitro activity of a new cephalosporin, RWJ-54428, against streptococci, enterococci and staphylococci, including glycopeptide-intermediate Staphylococcus aureusJana M Swenson, Fred C Tenover
The Journal of Antimicrobial Chemotherapy|May 11, 2002
Evaluation of two inhibitors of invasion: LY311727 [3-(3-acetamide-1-benzyl-2-ethyl-indolyl-5-oxy)propane phosphonic acid] and AEBSF [4-(2-aminoethyl)-benzenesulphonyl fluoride] in acute murine toxoplasmosisRafael Buitrago-Rey, Jorge Olarte, Jorge Enrique Gomez-Marin
The Journal of Antimicrobial Chemotherapy|July 4, 2002
Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo modelMurli U Purswani, Susan J Eckert, Harman K Arora, et al.
The Journal of Antimicrobial Chemotherapy|July 4, 2002
Macrolide-treated Pseudomonas aeruginosa induces paradoxical host responses in the lungs of mice and a high mortality rateTakao Kobayashi, Kazuhiro Tateda, Tetsuya Matsumoto, et al.
The Journal of Antimicrobial Chemotherapy|September 20, 2002
Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000Rafael Cantón, Elena Loza, M Isabel Morosini, et al.
The Journal of Antimicrobial Chemotherapy|September 20, 2002
Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycinDavid Felmingham, Ralf Rene Reinert, Yoichi Hirakata, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2002
Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparumB Pradines, J M Rolain, F Ramiandrasoa, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2002
Pharmacodynamic characterization of efflux and topoisomerase IV-mediated fluoroquinolone resistance in Streptococcus pneumoniaeKarl J Madaras-Kelly, Christopher Daniels, Marissa Hegbloom, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2002
How strong is the evidence that antibiotic use is a risk factor for antibiotic-resistant, community-acquired urinary tract infection?Sharon L Hillier, John T Magee, Anthony J Howard, et al.
Pageof 1,574